au.\*:("VON HOFF, D. D")
Results 1 to 25 of 256
Selection :
New agent development for women with breast cancerVON HOFF, D. D.Cancer investigation. 1995, Vol 13, Num 3, pp 341-344, issn 0735-7907Article
In vitro data supporting interferon plus cytotoxic agent combinationsVON HOFF, D. D.Seminars in oncology. 1991, Vol 18, Num 5, pp 58-61, issn 0093-7754, SUP7Article
MGBG : teaching an old drug new tricksVON HOFF, D. D.Annals of oncology. 1994, Vol 5, Num 6, pp 487-493, issn 0923-7534Article
In vitro predictive testing: the sulfonamide eraVON HOFF, D. D.International journal of cell cloning. 1987, Vol 5, Num 3, pp 179-190, issn 0737-1454Article
There are no bad anticancer agents, only bad clinical trial designs-twenty-first Richard and Hinda Rosenthal foundation award lectureVON HOFF, D. D.Clinical cancer research. 1998, Vol 4, Num 5, pp 1079-1086, issn 1078-0432Article
Human tumor cloning assay: applications in clinical oncology and new antineoplastic agent developmentVON HOFF, D. D.Cancer metastasis reviews. 1988, Vol 7, Num 4, pp 357-371, issn 0167-7659Article
Response rates, duration of response, and dose response effects in phase I studies of antineoplasticsVON HOFF, D. D; TURNER, J.Investigational new drugs. 1991, Vol 9, Num 1, pp 115-122, issn 0167-6997, 8 p.Article
Acid depurination after field inversion agarose gel electrophoresis reduces transfer of large DNA moleculesVAN DEVANTER, D. R; VON HOFF, D. D.Applied and theoretical electrophoresis. 1990, Vol 1, Num 4, pp 189-192, issn 0954-6642Article
New natural products in cancer chemotherapySLICHENMYER, W. J; VON HOFF, D. D.Journal of clinical pharmacology. 1990, Vol 30, Num 9, pp 770-788, issn 0091-2700, 19 p.Article
Effect of recombinant interferon-βser on primary human tumor colony-forming unitsVON HOFF, D. D; MAI HUONG, A.Journal of interferon research. 1988, Vol 8, Num 6, pp 813-820, issn 0197-8357, 8 p.Article
Cytotoxicity of 2-chlorodeoxyadenosine in a human tumor colony-forming assayHUTTON, J. J; VON HOFF, D. D.Cancer drug delivery. 1986, Vol 3, Num 2, pp 115-122, issn 0732-9482Article
Mitoxantrone: a new anticancer drug with significant clinical activitySHENKENBERG, T. D; VON HOFF, D. D.Annals of internal medicine. 1986, Vol 105, Num 1, pp 67-81, issn 0003-4819Article
Phase I trials of dexrazoxane and other potential applications for the agentVON HOFF, D. D.Seminars in oncology. 1998, Vol 25, Num 4, pp 31-36, issn 0093-7754, SUP10Article
Possible mitoxantrone-induced amenorrheaSHENKENBERG, T. D; VON HOFF, D. D.Cancer treatment reports. 1986, Vol 70, Num 5, pp 659-661, issn 0361-5960Article
Drug sensitivity testing of carcinoma of the gallbladder and biliary tree in a human tumor cloning assayHARRIS, G. J; VON HOFF, D. D.Cancer drug delivery. 1986, Vol 3, Num 3, pp 197-204, issn 0732-9482Article
Comparison of the human tumor cloning and subrenal capsule assays = Comparaison entre le clonage de tumeur humaine et le test de la capsule rénaleBOGDEN, A. E; VON HOFF, D. D.Cancer research (Baltimore). 1984, Vol 44, Num 3, pp 1087-1090, issn 0008-5472Article
Use of a human tumor cloning system to evaluate analogs of methotrexate and mitoxantrone = Utilisation d'un système de clonage des tumeurs humaines pour évaluer des analogues du méthotrexate et de la mitoxantroneLATHAN, B; VON HOFF, D. D; ELSLAGER, E et al.Cancer treatment reports. 1984, Vol 68, Num 5, pp 733-738, issn 0361-5960Article
Prediction of response to cancer chemotherapySAROSDY, M. F; VON HOFF, D. D.Drugs (Basel). 1983, Vol 26, Num 5, pp 454-459, issn 0012-6667Article
Promising new agents for treatment of patients with colorectal cancerVON HOFF, D. D.Seminars in oncology. 1998, Vol 25, Num 5, pp 47-52, issn 0093-7754, SUP11Article
Growth of carcinoma of the esophagus and gastroesophageal junction in a human tumor cloning assayHARRIS, G. J; TURNER, J. N; VON HOFF, D. D et al.Cancer drug delivery. 1986, Vol 3, Num 4, pp 273-278, issn 0732-9482Article
A method for performing scanning electron microscopy of colonies growing in a human tumor cloning systemHARRIS, G. J; ZEAGLER, J; VON HOFF, D. D et al.International journal of cell cloning. 1985, Vol 3, Num 5, pp 286-293, issn 0737-1454Article
Androgen receptors and antiandrogen therapy for laryngeal carcinomaMATTOX, D. E; VON HOFF, D. D; MCGUIRE, W. L et al.Archives of otolaryngology (1960). 1984, Vol 110, Num 11, pp 721-724, issn 0003-9977Article
Hispanic patients with head and neck cancer do not have a worse prognosis than Anglo-American patientsHARRIS, G. J; CLARK, G. M; VON HOFF, D. D et al.Cancer. 1992, Vol 69, Num 4, pp 1003-1007, issn 0008-543XArticle
Use of a radiometric system to screen for antineoplastic agents: correlation with a human tumor cloning systemVON HOFF, D. D; FORSETH, B; WARFEL, L. E et al.Cancer research (Baltimore). 1985, Vol 45, Num 9, pp 4032-4038, issn 0008-5472Article
Activity of mitoxantrone and bisantrene in a human tumor cloning system = Activité de la mitoxantrone et du bisantrène dans un système de clonage tumoral humainCOWAN, J. D; CLARK, G; VON HOFF, D. D et al.Monograph series of the European Organization for Research on Treatment of Cancer. 1983, Vol 12, pp 39-46, issn 0146-0447Article
